Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. Mulberroside has nephroprotective, hypoglycemic, and antidiabetic effects. 2. Mulberroside A is a glycosylated stilbene of oxyresveratrol; thus, the deglycosylation of Mulberroside A resulted in enhanced inhibition of melanogenesis. 3. Mulberroside A has anti-inflammatory antiapoptotic effects. by decreasing the expressions of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6 and inhibiting the activation of NALP3, caspase-1, and nuclear factor-κB and the phosphorylation of extracellular signal-regulated protein kinases, the c-Jun N-terminal kinase, and p38.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 42.00 | |
5 mg | In stock | $ 92.00 | |
10 mg | In stock | $ 147.00 | |
25 mg | In stock | $ 267.00 | |
50 mg | In stock | $ 447.00 | |
100 mg | In stock | $ 646.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 116.00 |
Description | 1. Mulberroside has nephroprotective, hypoglycemic, and antidiabetic effects. 2. Mulberroside A is a glycosylated stilbene of oxyresveratrol; thus, the deglycosylation of Mulberroside A resulted in enhanced inhibition of melanogenesis. 3. Mulberroside A has anti-inflammatory antiapoptotic effects. by decreasing the expressions of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6 and inhibiting the activation of NALP3, caspase-1, and nuclear factor-κB and the phosphorylation of extracellular signal-regulated protein kinases, the c-Jun N-terminal kinase, and p38. |
Targets&IC50 | Monophenolase:1.29 μmol/L |
Source |
Molecular Weight | 568.52 |
Formula | C26H32O14 |
CAS No. | 102841-42-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (96.74 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mulberroside A 102841-42-9 Apoptosis Immunology/Inflammation Proteases/Proteasome Interleukin TNF Tyrosinase Tumor Necrosis Factor Receptor inhibit TNF Receptor TNFR Inhibitor Interleukin Related inhibitor